School of Medicine
  • Print
Researcher looking at bacteria in a bottle

Cancer and Stem Cells

Research on why cancer and disease develop and how they can be best prevented and treated is mostly carried out by groups within the Division of Cancer and Stem Cells.

Postgraduate Research Opportunities

Cancer and Stem Cells Research Groups
GroupAim
Academic Haematology

To learn more about learn more about the biology of the diseases, discover and characterise new drug targets, test new drugs, and to identify better treatments for people with blood-related disorders.

Academic Pathology To study the pathology of breast disease, colorectal cancer, inflammatory bowel disease and gynaecological disease.
Breast Cancer Research Centre We focus on breast cancer at all levels, aiming to detect it early, stop it spreading and treating it correctly.
Breast Pathology Group To refine breast cancer prognostication and outcome prediction, identify new targets for therapeutic development and improve patient management.
Breast Surgery To improve the outcome of individuals with breast cancer.
Cancer Biology Unit Working on the biological basics of cancer, and how we can use this to translate new findings on mechanisms and cancer processes into novel therapeutic approaches for cancer and other diseases.
Cancer Epidemiology To study the causes and outcomes of cancer and strategies for early detection.
Cancer Immunotherapy To study the alterations in cancer antigens and exploit these in the development of therapies.
Centre for Cancer Sciences A dedicated research environment, bringing together staff and students at all stages of their careers to benefit from a dynamic interdisciplinary structure that enables the next generation of breakthroughs in cancer science.
Centre of Excellence for Autoimmunity in Cancer (CEAC) To bring together experts from around the world are a multi-disciplinary team from across the globe, sharing knowledge and working together with industry to not just make cutting edge cancer treatment breakthroughs, but assist getting them to market – thus saving lives - quickly.
Children's Brain Tumour Research Centre To develop new and better methods of treating childhood brain cancer, and improving the quality of life of children who are cured.
Epigenetic Basis of Disease To provide a detailed knowledge of the mechanisms regulating gene expression in normal cell differentiation and in disease, information that is fundamental for the identification of new disease markers and for the design of novel drugs and therapies to tackle individual disease cases.
Ex Vivo Cancer Pharmacology Centre of Excellence To develop patient-relevant models that accurately predict clinical efficacy of a new range of anti-cancer drugs.
GI and Liver Diseases Medical and Surgical Research To conduct international quality research relating to gastrointestinal and liver disease including clinical trials and population studies and to translate laboratory medicine and surgery into clinical interventions which improve the care and lives of our patients.
Host-Tumour Interactions Group To understand unique molecular mechanisms responsible for immune deviation in patients with advanced cancer.
Molecular Pathology Group To develop an understanding of the molecular basis of neoplastic and inflammatory gastrointestinal disease and use this to improve patient care.
Neural and Cancer Stem Cell Interested in understanding the particularities of stem cells, at the molecular level, in order to come up with new means of manipulating them in culture, in experimental models of disease, and, finally, in the patient.
Stem Cell Biology To foster new opportunities to maximise translation of our fundamental stem cell biology.
Surgery To better understand how cancer develops and create tools for its early detection and novel therapies to prevent or control its progression.
Translational DNA Repair To target DNA repair for personalized cancer therapy.
Translational and Radiation Biology To understand how cancers respond to therapies (conventional radiotherapy, chemotherapy and targeted therapies), and what mediates their resistance - by understanding resistance mechanisms we hope to develop novel means to improve response.

School of Medicine

University of Nottingham
Medical School
Nottingham, NG7 2UH

Contacts: Please see our 'contact us' page for further details